| Entries |
| Document | Title | Date |
|---|
| 20100093871 | AGENT FOR PREVENTION OR TREATMENT OF IRON OVERLOAD DISORDERS - Disclosed is an agent for prevention or treatment of iron overload disorders, comprising 22β-methoxyolean-12-ene-3β,24(4β)-diol or a pharmacologically acceptable salt thereof. | 04-15-2010 |
| 20100184866 | Dual Cation Dual Anion Coordination Complexes - Compounds are provided herein which are coordination complexes of the formula, A | 07-22-2010 |
| 20100210733 | Composition for Prevention or Treatment of Bone Metabolism Disorder Comprising D-Pinitol as an Active Ingredient - The present invention provides a composition for inhibiting osteoclastogenesis and a pharmaceutical composition for preventing or treating a bone metabolism disorder, which comprise D-pinitol as an active ingredient. The present compositions have an inhibitory activity on the differentiation of osteoclast and are useful in the prevention or treatment of a bone metabolism disorder resulting from overactivity or hyper-proliferation of osteoclasts. | 08-19-2010 |
| 20110071225 | METHOD FOR OBTAINING A SEQUOYITOL-CONTAINING EXTRACT FROM GENUS NEPHROLEPIS AND USES THEREOF - A method for obtaining a sequoyitol-containing extract from a plant of genus | 03-24-2011 |
| 20110294901 | FINELY PULVERIZED PHARMACEUTICAL COMPOSITION - An objective of the present invention is to provide a composition that has improved oral absorption and comprises a slightly soluble drug, and to provide a process for producing the same. According to the present invention, there is provided a finely pulverized composition comprising a slightly soluble drug such as 22β-methoxyolean-12-ene-3β, 24(4β)-diol and a hydrophilic surfactant. According to the present invention, there is also provided a process for producing the finely pulverized composition according to the present invention, characterized in that, after the dispersion of a slightly soluble drug and a hydrophilic surfactant in a solvent, the dispersion is pulverized with a high-pressure homogenizer. | 12-01-2011 |
| 20120022168 | Pest Control Agent, Method for Manufacture of Pest Control Agent, and Method for Pest Control - Disclosed are a pest control agent, a method for preparing a pest control agent, and a method for controlling a pest. Generally, the pest control agent is formed by providing a porous starch and an active control agent absorbed within the porous starch, and compressing the porous starch in the presence of heat to form discrete plural particles. Preferably, one or more binders are employed, as are one or more secondary absorbents/fillers. In highly preferred embodiments of the invention, the pest control agent is prepared via pelletizing in a commercial pellet mill. The particles so prepared should be sufficiently durable to withstand bulk transport, such as by rail car or bag shipment. The particles should, however, release the control agent quickly upon contact with water, such that, for instance, the control agent may be released when the pest control agent is introduced to standing water. It is contemplated that the control agent is preferably a mosquito control agent. | 01-26-2012 |
| 20130123370 | Compositions and methods for treating Alzheimer's disease and related disorders and promoting a healthy nervous system - Methods of inhibiting the onset and progression of Alzheimer's disease (AD), mild cognitive impairment (MCI), and related neurodegenerative disorders involving amyloidosis are provided. The methods involve administering a composition comprising a therapeutically effective amount of D-pinitol to individuals who are at risk of developing the disease or have one or more symptoms of the disease. Also provided are methods of treating or preventing Alzheimer's disease or MCI that involve the use of such compositions. Also provided are methods of using D-pinitol to promote a healthy nervous system and as a food supplement. | 05-16-2013 |
| 20140357725 | TERPENE ANALOGUES AND USES THEREOF FOR TREATING NEUROLOGICAL CONDITIONS - The present application provides terpene analogues of Formula 1 and methods and uses thereof for treating neurological conditions such as pain in general and neuropathic pain specifically. | 12-04-2014 |
